Difficulty: Medium
Average Score: 68%
Practice
Which of the following is the most suitable anti malarial drug for pregnant women?
Correct answer
C
Rationale
The most suitable anti-malarial drug for pregnant women is option C) Quinine and clindamycin. Quinine is often recommended during pregnancy for the treatment of malaria due to its long history of safe use in pregnant women. Clindamycin is commonly combined with quinine to improve efficacy and reduce the duration of treatment.
Option A) Atovaquone and proguanil are not recommended in pregnancy due to limited safety data, especially in the first trimester where drug exposure can potentially harm the developing fetus.
Option B) Quinine and doxycycline should be avoided in pregnancy as doxycycline is contraindicated due to its potential to cause harm to the fetus, particularly affecting bone and teeth development.
Option D) Primaquine is not suitable for use in pregnant women, especially during the first trimester, as it can cause hemolysis in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency, which can be harmful to both the mother and the developing fetus.
In an educational context, understanding the safety profiles of medications in pregnancy is crucial for healthcare providers to make informed decisions to ensure the well-being of both the mother and the unborn child. It is essential to consider the risks and benefits of each medication and select the most appropriate treatment based on the individual patient's condition and pregnancy status.
Option A) Atovaquone and proguanil are not recommended in pregnancy due to limited safety data, especially in the first trimester where drug exposure can potentially harm the developing fetus.
Option B) Quinine and doxycycline should be avoided in pregnancy as doxycycline is contraindicated due to its potential to cause harm to the fetus, particularly affecting bone and teeth development.
Option D) Primaquine is not suitable for use in pregnant women, especially during the first trimester, as it can cause hemolysis in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency, which can be harmful to both the mother and the developing fetus.
In an educational context, understanding the safety profiles of medications in pregnancy is crucial for healthcare providers to make informed decisions to ensure the well-being of both the mother and the unborn child. It is essential to consider the risks and benefits of each medication and select the most appropriate treatment based on the individual patient's condition and pregnancy status.